Innovation and the Pharmaceutical Industry
| Critical Reflections on the Virtues of Profit Edited by H. Tristram Engelhardt, Jr. and Jeremy R. Garrett Series: Conflicts and Trends: Studies in Values and Policies Copyright: 2008 | Status: Published ISBN: 9780980209440 | Hardcover | 1.25 lbs 252 pages Price: $69 USD |
One Line DescriptionBalancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade.
Audience
· Professionals (managers, scientists, lawyers) working in drug development in the pharmaceutical industry.
· Business ethicists and bioethicists in business, academic, and industry settings.
· Health policy experts
· Health lawyers
DescriptionInnovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally. Recent efforts to understand this role have often underestimated and even dismissed its importance, arguing for its replacement by other means and mechanisms. However, as the essays in this volume attest, it would be impossible to account adequately for the range of pharmaceuticals and medical devices that have become part of everyday medicine without recognizing that the depth and scope of innovations are tied not simply to altruism, a concern for the common good, or the pursuit of knowledge for its own sake, but crucially to the pursuit of private good and of individual profit.
Balancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade. Reflecting critically on the problems and prospects of medical innovation, they invite a rethinking of the foundations of the bioethics and business ethics of the pharmaceutical and medical device industries by focusing on the long-term impact of policy decisions for human health and well-being.
Back to Top Reviews
"Engelhardt and Garrett have assembled a sorely needed text bringing clarity to the brassy, yet one-dimensional, criticisms of profit in the pharmaceutical industry. It would certainly serve as a foundational reference for those in the pharmaceutical and medical device industry, those interested in bioethics or medical business ethics, or anyone looking for a more balanced account of this debate. Innovation and the Pharmaceutical Industry is the reigning exposition on why the market and the pursuit of profit are the superior mechanism."
Erica K. Rangel, HEC Forum
"This book will prove indispensable in future debate on the appropriate place of profit in the pharmaceutical industry."
Cambridge Quarterly of Healthcare Ethics
Back to TopAuthor / Editor DetailsH. Tristram Engelhardt, Jr., holds degrees in both medicine and philosophy. He is Professor in the Department of Philosophy at Rice University, Professor Emeritus in the Department of Medicine, Baylor College of
Back to TopBISAC SUBJECT HEADINGSPHI015000: Philosophy/Ethics & Moral Philosphy
MED050000: Medical Ethics
BUS02000: Business & Economics/Development/Business Development
BIC CODESPSAD: Bioethics
KNDP: Pharmaceutical Industries
Back to Top